ArticleEuropean journal of public health2026
Factors related to participation in colorectal cancer screening in a Southern European region: a prevalence survey.
Article in European journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The colorectal cancer screening programme was fully implemented in the Community of Madrid in 2019. This study aimed to analyse factors related to participation during the subsequent 4 years. We conducted a cross-sectional study using data from the Community of Madrid's Noncommunicable Disease Risk-Factor Surveillance System (SIVFRENT) (2020-23). Study population included individuals aged 50-69 years. We analysed the association between faecal occult blood test (FOBT) performance and demographic, socioeconomic, and lifestyle variables. Crude and adjusted prevalence ratios (aPR) were calculated using Poisson regression models, stratified by sex. Among 3813 participants, 52.1% were women. Overall, 55.3% (95% CI: 53.6-57.0) underwent an FOBT for screening purposes, with a greater proportion of men (57.8%) than women (53.1%) (P < .05). The highest participation occurred during 2023. Among men, being separated or divorced (aPR: 0.80; 95% CI: 0.67-0.94) and being aged 50-59 years old (aPR: 0.92; 95% CI: 0.85-0.99) were associated with a lower likelihood of undergoing an FOBT. Among women, lower participation was associated with being underweight (aPR: 0.63; 95% CI: 0.40-0.97), widowed (aPR: 0.78; 95% CI: 0.66-0.93), born outside Spain (aPR: 0.82; 95% CI: 0.72-0.95), a current smoker (aPR: 0.84; 95% CI: 0.75-0.95), and being under 60 years of age (aPR: 0.86; 95% CI: 0.79-0.94). Overall, a gradual improvement in colorectal cancer screening participation was observed, with men participating at higher rates than women. The associated factors differ between men and women and need to be accounted for when strategies to increase programme coverage are implemented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.